Updated Jul 16, 2026
MOATAZEDI DAVID is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $749K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-20 | EOLS | Evolus, Inc. | S — Open-market sale [10b5-1] | 13.7K | $4.75 | $65K |
| 2026-03-19 | EOLS | Evolus, Inc. | S — Open-market sale [10b5-1] | 116.7K | $4.89 | $571K |
| 2026-03-19 | EOLS | Evolus, Inc. | M — Option exercise [10b5-1] | 67.5K | $0.00 | |
| 2026-02-20 | EOLS | Evolus, Inc. | A — Grant or award | 313.2K | $0.00 | |
| 2025-12-31 | BMRA | BIOMERICA INC | A — Grant or award | 20.0K | $0.00 | |
| 2024-12-26 | EOLS | Evolus, Inc. | S — Open-market sale [10b5-1] | 10.5K | $10.85 | $114K |
| 2024-12-17 | BMRA | BIOMERICA INC | A — Grant or award | 85.0K | $0.31 | $26K |
MOATAZEDI DAVID is a corporate insider — currently tracked as See Remarks, Director. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($749K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live MOATAZEDI DAVID profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.